| LZISX | TIDDX | LZISX / TIDDX | |
| Total Expense Ratio | 1.03 | 1.08 | 95% |
| Annual Report Gross Expense Ratio | 2.33 | 1.08 | 216% |
| Fund Existence | 32 years | 10 years | - |
| Gain YTD | 10.009 | 5.888 | 170% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 10000 | 500000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 14.3M | 6.44B | 0% |
| Annual Yield % from dividends | 1.76 | 1.61 | 109% |
| Returns for 1 year | 44.99 | 26.44 | 170% |
| Returns for 3 years | 47.52 | 35.08 | 135% |
| Returns for 5 years | -7.14 | -12.75 | 56% |
| Returns for 10 years | 32.85 | 74.46 | 44% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GGSYX | 17.15 | 0.12 | +0.70% |
| Grandeur Peak Global Stalwarts Instl | |||
| MYIMX | 25.47 | 0.14 | +0.55% |
| Victory Integrity Mid-Cap Value Y | |||
| FRBRX | 182.81 | 0.78 | +0.43% |
| Franklin Biotechnology Discovery R6 | |||
| FNCMX | 299.43 | N/A | N/A |
| Fidelity Nasdaq Composite Index | |||
| PAECX | 19.87 | -0.08 | -0.40% |
| Putnam Dynamic Asset Allocation Gr C | |||